Startup Series: Meet RespiQ, the future of digestive health

In the coming weeks, we will be introducing our first Amsterdam cohort's startups. Today we will hear from the founders of RespiQ, a startup that is building a cutting edge, patent-pending technology based on proven science.

Portrait of Antler

Antler

Company

Startup Series: Meet RespiQ, the future of digestive health

In this fast-paced society, everyone wants to run faster with a healthy body. Food impacts everyone's health, and whilst there is no standard to measure if anyone is healthy or not, anyone can take a practical solution to determine if they are in good health - and how to improve based on simple metrics with validated dietary guidance they can trust.

RespiQ, one of the 11 funded startups from the first Antler Amsterdam cohort, provides smart breath testing to allow you to make smarter dietary choices to improve your health. By analyzing biomarkers in the breath, they can detect your personal intolerances to certain foods. They aim to provide "accurate, non-invasive and affordable technology" for early detection of health issues through breathing.

As a well-trained gymnast, and just as anyone else that is active and wants to keep track of their health, Mira Gleisberg, CEO & co-founder of RespiQ, deeply understands the urge of something convenient and effective for wellbeing and early detection. Therefore, she decided to go cut in through breath testing, which is already being used in hospitals as a fast, easy way to diagnose intolerances. An experienced healthcare expert at Philips and ex-McKinsey healthcare consultant, she is excited to bring this idea to life.

Vitalii Vorkov, CTO of RespiQ as well as the inventor of the technology, had been excited for this opportunity to work on something that can help millions of people take control of their wellbeing on a daily basis. As a highly-seasoned full-stack mechanical engineer, he believed that innovation was a synonym of success. By participating in the Antler program and working with co-founder Mira on RespiQ, he was "in the right place to bring advanced health solutions to society."

Interested in the team that is passionately building this simple but effective solution to target your health concerns? Watch this video to learn more about them. If you want a head start in becoming a beta tester of this exciting new device, sign up here.

Transcript:

Mira: We are building a simple and affordable breath test that can be used anywhere to measure biomarkers in the breath. One in four people often experience digestive issues, and this can really impact your mood and your energy. 30% of the cases is caused by food intolerance, and it impacts around 5 hundred million people globally.

Vitalii: Mira and I have been working on this together. I don't think we would have ever met if we were not in this (Antler) environment. I'm an engineer, and this is a great opportunity for me to improve the lives of a lot of people.

Mira: I used to be a top gymnast. I've always been very focused on improving, optimizing my performance, my diet, and my health. And I also learnt that health is not the same for everyone. There is so much information out there, but there's not any practical solution that helps you to identify what works for you. Now we at RespiQ we have the ability to change that. People can take full control of their own health and wellbeing.

More from Residency

Residency

What if [Google] does it?

There are tons of different frameworks on what makes a good business idea. However, there is one point in particular that is tough to crack: “What if [Google] does it?”—i.e., if the big incumbent that is playing in the same or an adjacent market uses their vast resources to copy you, what chance do you even have? This is what in German we call a Totschlagargument, which in our loving and peaceful language translates roughly into “the argument with which you can beat anything to death”. And it is easy to dismiss the question because in so many cases startups have prevailed against much larger incumbents. But I believe a more nuanced view is needed. In reality, these incumbents pose a legitimate threat in many cases and they have ended countless hopeful startups. I discuss this topic frequently—both with founders considering whether to dedicate a decade of their life to something, and with colleagues when we’re thinking about being the first investor—but haven't found a great framework. Here are the key questions that help me wrap my head around this:

Residency

The next wave of innovation: 27 industry trends set to define 2024

What will innovation look like as we move deeper into 2024? What are the biggest industry trends that will define the coming year? We asked our global network of Antler Operators—founders, sector leaders, CxOs, and VPs from companies including Roblox, Airtable, Shopify, Spotify, Affirm, DoorDash, Uber, Hubspot, and more, who offer 1:1 advice to Antler portfolio companies, giving them extra firepower to help fast-track their growth.

Residency

12 MINUTES—Episode 3: Kilian Martin from Physikit

12 MINUTES with Antler founders gives a closer look into the journey of founders toward successfully building their ventures. Every first Wednesday of the month Alan Poensgen, Antler Partner in Germany, sits down with a founder of an Antler portfolio company and talks about their time at Antler, the team formation, the ideation process, and more.

Residency

12 MINUTES — Episode 2: Dean Hastie from Tapline

12 MINUTES with Antler founders gives a closer look into the journey of founders toward successfully building their ventures. Every first Wednesday of the month Alan Poensgen, Antler Partner in Germany, sits down with a founder of an Antler portfolio company and talks about their time at Antler, the team formation, the ideation process, and more.

Residency

Antler in Berlin welcomes new additions to the Antler portfolio

What a day! On Wednesday 28th June all of Antler portfolio companies met up together with more than 150 investors, other founders, and executives. It was a day full of inspiration, insightful conversations, and a great opportunity to keep the spirits up when the times for start-ups are hard. After the panel discussion led by Christopher Klink, partner at Antler Germany, where Emilia Theye, co-founder of Clare&Me, Tore Myrholt, Chairman of the Board at Antler, and Emma Tracey, CEO at Scéal shared their insights and perspectives on the early-stage ecosystem in the region and beyond as well as gave advice to founders and investors. They also concluded that despite hard times, there is a lot of light and positive expectations for the years to come!

Residency

12 MINUTES – Episode 1: Christian Poensgen from Maya Climate

12 MINUTES with Antler Founders gives a closer look into the journey of founders toward successfully building their ventures. Every first Wednesday of the month Alan Poensgen, Antler Partner in Germany, sits down with a founder of an Antler portfolio company and talks about their time at Antler, the team formation, the ideation process, and more.